Vaxcyte Inc (PCVX)
88.54
+0.15
(+0.17%)
USD |
NASDAQ |
Nov 22, 16:00
89.00
+0.46
(+0.52%)
After-Hours: 20:00
Vaxcyte Shareholders Equity (Quarterly): 3.418B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.418B |
| June 30, 2024 | 1.986B |
| March 31, 2024 | 1.984B |
| December 31, 2023 | 1.240B |
| September 30, 2023 | 1.403B |
| June 30, 2023 | 1.433B |
| March 31, 2023 | 944.77M |
| December 31, 2022 | 953.61M |
| September 30, 2022 | 359.31M |
| June 30, 2022 | 366.50M |
| Date | Value |
|---|---|
| March 31, 2022 | 359.54M |
| December 31, 2021 | 284.02M |
| September 30, 2021 | 305.96M |
| June 30, 2021 | 317.02M |
| March 31, 2021 | 326.94M |
| December 31, 2020 | 345.84M |
| September 30, 2020 | 364.08M |
| June 30, 2020 | 383.21M |
| March 31, 2020 | 137.85M |
| December 31, 2019 | -106.37M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-106.37M
Minimum
Dec 2019
3.418B
Maximum
Sep 2024
840.33M
Average
365.29M
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc | 92.29B |
| Merck & Co Inc | 44.50B |
| Embecta Corp | -763.70M |
| Arrowhead Pharmaceuticals Inc | 330.55M |
| Dyne Therapeutics Inc | 705.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.560B |
| Total Liabilities (Quarterly) | 142.11M |